Jeffrey L. Wade, EVP, Corporate Adm Affairs and CFO at LEXICON PHARMACEUTICALS, INC. (LXRX), bought 2,000 shares at $9.48 ($19K) on 2017-11-14, disclosed to the SEC on 2017-11-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |